November 2025 - Best Abstract From ESCP 2025 Meeting

Pre-treatment SEPTIN9 Gene Methylation Ratio Predicts Tumor Response to Total Neoadjuvant Therapy in Locally Advanced Rectal Cancer

This month, we feature a conversation between Dr. Tryliskyy and Dr. Domínguez-Prieto, discussing the Best Abstract Award from the recent ESCP 2025 Meeting in Paris.
In this focused exchange, they explore the key aspects of the study — from its basic science background and methodological approach to the main findings and their potential clinical implications for rectal cancer management.